重组链激酶

目的观察国产重组链激酶（rSK）对下肢急性深静脉血栓形成的疗效和安全性。

Purpose To evaluate the efficacy and safety of intravenous recombinant streptokinase ( r-SK ) in treatment of patients with acute deep veinous thrombosis of the lower limbs ( ADVT ) .

结论重组链激酶治疗下肢非急性期深静脉血栓形成的早期疗效优于国产尿激酶，但药物不良反应较多。影响改良Bentall手术后早期疗效的危险因素分析

Conclusions The early efficacy of recombinant streptokinase was superior to that of urokinase , but its side effect is also more frequent than the latter . Analysis of Perioperative Risk Factors for Early Outcome after Modified Bentall Operation

急诊应用瑞替普酶、重组链激酶溶栓治疗ST段抬高型心肌梗死临床分析

Comparison of Curative Effect of Reteplase and Recombinant Streptokinase in the Patients with ST-Elevation Myocardial Infarction

院前溶栓组患者是在发病现场，诊断AMI后立即给重组链激酶150万U静脉点滴。

The patients in treatment group were immediately given recombination streptokinase 15 million U by intravenous drip in AMI onset site .

目的观察重组链激酶与尿激酶治疗急性心肌梗死（AMI）的疗效、副作用及缺血再灌注损伤。

Objective : To observe the therapeutic effect , side effects and ischemia-reperfusion injury of the thrombolytic therapy treated with recombinant streptokinase or with urokinase .

对比分析国产基因重组链激酶和德国链激酶静脉溶栓治疗急性心肌梗塞（AMI）的有效性和安全性。

OBJECTIVE : To compare the efficacy and safety of China made gene recombined Streptokinase ( rSK ) and German made streptokinase ( SK ) in the treatment of acute myocardial infarction ( AMI ) .

目的：探讨基因重组链激酶（rSK）对腹腔粘连的预防价值。

Objective : To evaluate the value of recombined - streptokinase ( r - SK ) in the prevention of peritoneal adhesion .

重组链激酶以6、30、150万IU／kg的剂量水平给大鼠腹腔注射，观察毒性反应。

Three dose levels of r-SK ( 60000 , 300000 and 1500000 IU / kg ) were given ip to rats for 28 consecutive days respectively to observe the toxicity of r-SK , a similar group served as a control .

重组链激酶对大鼠凝血功能的影响及其毒性

Effect on blood coagulation function and toxicity of recombinant streptokinase in rats

重组链激酶在急性下肢深静脉血栓形成中的应用

Application of recombinant streptokinase in acute deep venous thrombosis of lower extremities

基因重组链激酶在高血压脑性出血抽吸中的应用

Use of recombinant streptokinase in treatment of hypertensive cerebral hemorrhage

重组链激酶对犬冠状动脉栓塞的作用

Effects of recombinant streptokinase on coronary thrombotic occlusion in canine

重组链激酶治疗幼猪急性脑梗死的药效学基因工程链激酶的中试研究

Pharmacodynamics of recombinant streptokinase in treatment of acute thromboembolic stroke of swine

重组链激酶及其三种突变体的活性研究

Activity Studies on the Recombinant Streptokinase and its Three Mutants

重组链激酶在脑内血肿动物模型中的局部应用

Lysis of intracerebral hematomas with recombinant streptokinase in cat

氯吡格雷联合重组链激酶溶栓治疗急性心肌梗死的临床研究

The Clinical Observation of Recombinant Streptokinase Joint Clopidogrel for Patients with Acute Myocardial Infarction

脑池应用重组链激酶预防猪迟发性脑血管痉挛

Effect of Recombinant Streptokinase on Preventing Pigs from Delayed Cerebral Vasospasm after Subarachnoid Hemorrhage

重组链激酶不同给药途径在猪急性脑栓塞模型中溶栓作用的实验研究

Recombinant streptokinase : comparison of route of administration in pig model of thromboembolic stroke

基因重组链激酶治疗急性心肌梗死20例疗效观察

Therapeutic effect of r-SK on acute myocardial infarction : a report of 20 cases

重组链激酶与尿激酶治疗急性心肌梗死的对比研究

A Comparative Study on Recombinant Streptokinase and Urokinase in Treatment of Acute Myocardial Infarction

结论国产重组链激酶为治疗急性心肌梗塞有效、安全的溶栓药物。

Conclusion Domestic recombinant streptokinase is an effective , reliable and safe thrombolytic agent .

局部动脉内灌注重组链激酶治疗急性脑梗死的临床研究

Clinical study of therapy for acute cerebral infarction through local intra-arterial infusion with recombinant streptokinase

重组链激酶治疗下肢急性深静脉血栓的疗效

Clinical Effects of r-SK in Treatment of Patients with Acute Deep Thrombosis of the Lower Limbs

重组链激酶腹腔灌注预防大鼠腹腔粘连的实验研究

Experimental study on prevention of the peritoneal adhesion by intracavity perfusion of recombined - streptokinase in rats

重组链激酶治疗急性脑梗死出凝血功能的动态变化

Kinetic changes of hemostatic function in patients with acute cerebral infarction treated by r-SK in 24 hours

国产重组链激酶溶栓对急性心肌梗死病人心功能储备的影响

The effect of thrombolytic therapy with domestic r-SK on the storage of heart function in acute myocardial infarction

国产重组链激酶与尿激酶在急性心肌梗死溶栓中的血管再通率的比较

The comparison of the repass rate between homemade recombined streptokinase and urokinase in thrombolytic therapy of acute myocardial infarction

重组链激酶溶栓治疗后急性心肌梗死患者纤溶活性及血管活性物质的改变

Changes of Plasma Fibrinolytic Activities and Vasoactive Substances in Patients With Acute Myocardial Infarction After Thrombolytic Therapy by Recombinant Streptokinase

目的讨论基因重组链激酶在治疗高血压脑出血破入脑室中的作用。

Objective To study the local use of gene recombinant streptokinase ( r sk ) in the treatment of hypertensive cerebral hematoma broken into ventricles of the brain .

目的：探讨重组链激酶溶栓治疗后急性心肌梗死患者血浆纤溶活性及血管活性物质的改变及其相互关系。

Objective : To study the changes of plasma fibrinolytic activities and vasoactive substances and the interaction between these substances in patients with acute myocardial infarction ( AMI ) after thrombolytic therapy by recombinant streptokinase ( r SK ) .